Evidence map›Paper›PMID 21698506›Full record

ArticleParasitology research2012

Isolation and characterisation of acaricidal and larvicidal novel compound (2S,5R,6R)-2-hydroxy-3,5,6-trimethyloctan-4-one from Streptomyces sp. against blood-sucking parasites.

Thimiri Lakshmipathi Deepika, Krishnan Kannabiran, Venkatesan Gopiesh Khanna, Govindasamy Rajakumar, Chidambaram Jayaseelan, Thirunavukkarasu Santhoshkumar, Abdul Abdul Rahuman

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 39 citations in OpenAlex.

  1. ExploringMicrobiology (Reading, England) · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Thimiri Lakshmipathi DeepikaBiomolecules and Genetics Division, School of Biosciences and Technology, VIT University, Vellore, 632 014, Tamil Nadu, India.
Krishnan Kannabiran
Venkatesan Gopiesh Khanna
Govindasamy Rajakumar
Chidambaram Jayaseelan
Thirunavukkarasu Santhoshkumar
Abdul Abdul Rahuman
Vellore Institute of Technology University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to assess the acaricidal and larvicidal property of marine actinobacterial compound (2S,5R,6R)-2-hydroxy-3,5,6-trimethyloctan-4-one extracted and isolated from Streptomyces sp. VITDDK3 tested against the larvae of Rhipicephalus (Boophilus) microplus Canestrini (Acari: Ixodidae), Anopheles subpictus Grassi and Culex quinquefasciatus Say (Diptera: Culicidae). The isolate was taxonomically characterised, identified and designated as Streptomyces sp. VITDDK3. The crude compound was loaded on silica gel column and eluted with chloroform-methanol-water. The purity of the compound isolated was analysed by thin layer chromatography using chloroform and methanol as the solvent system and confirmed by high-performance liquid chromatography. The structure of the purified compound was established from infrared, ultraviolet, (1)H-nuclear magnetic resonance (NMR), (13)C-NMR and mass spectral data. The chemical shift assignments obtained for the aliphatic compound from (1)H-NMR corresponding to the molecular formula C(11)H(22)O(2). Bioassay-guided fractionation led to the isolation of compound, which was identified as (2S,5R,6R)-2-hydroxy-3,5,6-trimethyloctan-4-one. In the present study, Streptomyces sp. VITDDK3 crude extract and different fractions were tested against the larvae of parasites at a concentration of 1,000 ppm. Those fractions showing 100% mortality in 24 h alone was selected for further column chromatographic separation. The purified compound (2S,5R,6R)-2-hydroxy-3,5,6-trimethyloctan-4-one was tested in the concentrations of 250, 200, 150, 100 and 50 ppm and observed the per cent mortality of 100, 88, 62, 50 and 36 against R. microplus; 100, 100, 87, 62 and 39 against A. subpitcus; and 100, 94, 79, 51 and 33 against C. quinquefasciatus, respectively. The crude extract showed parasitic effects after 24 h of exposure at 1,000 ppm, and parasite mortality was observed against the larvae of R. microplus (LC(50) = 88.74 ppm; r (2) = 0.865) against the larvae of A. subpictus (LC(50) = 162.59 ppm; r (2) = 0.817) and against C. quinquefasciatus (LC(50) = 120.15 ppm; r (2) = 0.782), respectively. The maximum efficacy was observed in purified marine actinobacterial compound (2S,5R,6R)-2-hydroxy-3,5,6-trimethyloctan-4-one with LC(50) and r (2) values against the larvae of R. microplus (94.49 ppm; 0.982) and A. subpictus (69.65 ppm; 0.906) and against C. quinquefasciatus (82.82 ppm; 0.957), respectively. The control (distilled water) showed nil mortality in the concurrent assay.

Indexed as

AcaricidesAnimalsCulicidaeInsecticidesKetonesLarvaModels, MolecularMolecular StructureOctanolsPhylogenyRhipicephalusStreptomyces2-hydroxy-3,5,6-trimethyloctan-4-oneAcaricidesInsecticidesKetonesOctanols

Identifiers

PMID21698506
OpenAlexW2004087035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.